Psychemedics Corporation PMD
2.67
0.00
0.00%
as of 2 Mar
- Market cap
- $15.7M
- P/E
- 0.0×
Follow PMD
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
19.58 | 18.68 | 19.12 | 32.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
3.35 | 2.86 | 2.05 | 1.34 | 1.32 | 1.56 | 1.10 | 0.88 | 0.67 |
P/FCF ratio |
18.60 | 15.39 | 14.15 | 22.02 | 0.00 | 393.47 | 6.05 | 0.00 | 16.33 |
P/Operating CF |
40.89 | 55.99 | 22.26 | 53.22 | 24.66 | 68.95 | 14.64 | 29.39 | 12.90 |
P/B ratio |
8.38 | 6.10 | 4.66 | 3.00 | 2.25 | 3.18 | 2.58 | 2.92 | 2.56 |
Price to Tangible BV |
8.38 | 6.10 | 4.66 | 3.00 | 2.25 | 3.18 | 2.58 | 2.92 | 2.56 |
EV/Sales |
3.34 | 2.74 | 1.90 | 1.22 | 1.38 | 1.53 | 0.93 | 0.81 | 0.61 |
EV/EBITDA |
10.49 | 9.92 | 7.59 | 7.75 | 0.00 | 9.80 | 10.56 | 0.00 | 63.87 |
EV/Operating CF |
14.04 | 11.90 | 10.21 | 10.63 | (7.20) | 92.33 | 4.82 | (12.08) | 12.93 |
EV/FCF |
18.52 | 14.74 | 13.12 | 19.99 | (5.71) | 386.11 | 5.14 | (10.45) | 14.92 |
Quick Ratio |
2.17 | 2.99 | 3.15 | 1.98 | 2.20 | 1.51 | 1.54 | 1.20 | 1.45 |
Current Ratio |
2.41 | 3.28 | 3.42 | 2.20 | 2.44 | 1.76 | 1.74 | 1.45 | 1.82 |
Net Debt/EBITDA |
(0.04) | (0.44) | (0.59) | (0.79) | (0.53) | (0.19) | (1.86) | 6.61 | (7.26) |
Debt/Assets |
13.51% | 12.74% | 6.52% | 9.55% | 17.21% | 5.86% | 3.20% | 2.47% | 0.64% |
Debt/Equity |
0.22 | 0.18 | 0.09 | 0.16 | 0.33 | 0.10 | 0.06 | 0.05 | 0.01 |
Asset Turnover |
1.66 | 1.54 | 1.66 | 1.44 | 0.83 | 1.09 | 1.25 | 1.42 | 1.91 |
Operating CF/Net income |
1.39 | 1.49 | 1.73 | 2.79 | 1.06 | (0.62) | (4.51) | 0.36 | (0.50) |
Capex/Depreciation |
(0.88) | (0.43) | (0.39) | (0.58) | (0.23) | (0.05) | (0.06) | (0.06) | (0.04) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 48.96% | 35.77% | 24.54% | 8.67% | (26.31%) | (5.37%) | (9.42%) | (47.63%) | (31.54%) | |
| 28.38% | 23.75% | 17.81% | 5.87% | (14.98%) | (2.92%) | (5.38%) | (26.75%) | (18.03%) | |
ROIC |
41.99% | 36.86% | 38.35% | 15.40% | (27.45%) | 1.13% | (10.22%) | (36.42%) | (31.42%) |
Return on Tangible Assets |
33.87% | 28.53% | 22.93% | 8.63% | (25.92%) | (5.97%) | (12.29%) | (80.55%) | (44.02%) |
Average Days of Receivables |
54.66 | 41.26 | 41.30 | 41.29 | 99.98 | 99.55 | 58.97 | 61.20 | 46.80 |
Research and Development Expense of Revenue |
3.63% | 3.42% | 3.63% | 4.16% | 5.99% | 4.54% | 5.25% | 5.18% | 3.80% |
Selling, General and Administrative Expense of Revenue |
25.46% | 25.96% | 26.85% | 31.53% | 45.28% | 35.83% | 35.85% | 46.11% | 41.88% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
1.72% | 1.47% | 1.39% | 2.01% | 2.64% | 2.98% | 3.45% | 4.11% | 4.66% |
Graham Net Nets |
0.01 | 0.05 | 0.09 | 0.04 | (0.07) | 0.03 | 0.07 | 0.06 | 0.13 |
Graham Number |
8.89 | 9.21 | 7.98 | 4.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
5.11% | 5.35% | 5.23% | 3.06% | (13.75%) | (1.78%) | (3.91%) | (21.24%) | (14.29%) |
Free Cash Flow Yield |
5.38% | 6.50% | 7.07% | 4.54% | (18.32%) | 0.25% | 16.53% | (8.79%) | 6.13% |
Revenue per Share |
7.16 | 7.24 | 7.76 | 6.83 | 3.87 | 4.49 | 4.49 | 3.85 | 3.36 |
Operating CF per Share |
1.70 | 1.67 | 1.44 | 0.78 | (0.74) | 0.07 | 0.87 | (0.26) | 0.16 |
Capex per Share |
(0.37) | (0.22) | (0.22) | (0.30) | (0.15) | (0.03) | (0.03) | (0.03) | (0.01) |
Free Cash Flow per Share |
1.33 | 1.45 | 1.22 | 0.48 | (0.89) | 0.04 | 0.84 | (0.29) | 0.14 |
Cash per Share |
0.72 | 1.49 | 1.45 | 1.32 | 0.51 | 0.36 | 0.84 | 0.34 | 0.24 |
Shareholders Equity per Share |
2.87 | 3.40 | 3.41 | 3.05 | 2.27 | 2.21 | 1.91 | 1.16 | 0.87 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.87 | 3.40 | 3.41 | 3.05 | 2.27 | 2.21 | 1.91 | 1.16 | 0.87 |
Free Cash Flow |
7.26 | 7.95 | 6.74 | 2.63 | (4.93) | 0.23 | 4.70 | (1.64) | 0.84 |
Working Capital |
6.36 | 9.64 | 9.81 | 7.02 | 5.66 | 4.46 | 4.25 | 2.10 | 2.23 |
Capital Expenditures |
(2.01) | (1.20) | (1.19) | (1.68) | (0.85) | (0.18) | (0.19) | (0.16) | (0.09) |
Net Current Asset Value |
1.43 | 5.98 | 7.64 | 2.14 | (1.89) | 0.98 | 2.00 | 1.15 | 1.75 |
EV/EBIT |
12.88 | 13.34 | 10.64 | 15.28 | 0.00 | 182.89 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.05 | 0.03 | 0.03 | 0.04 | 0.04 | 0.01 | 0.01 | 0.01 | 0.00 |
Net Profit Margin |
17.13% | 15.42% | 10.74% | 4.09% | (18.07%) | (2.67%) | (4.29%) | (18.80%) | (9.45%) |
Price to Operating Income |
12.93 | 13.93 | 11.47 | 16.83 | 0.00 | 186.38 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.17 | 0.24 | 0.30 | 0.27 | 0.39 | 0.55 | 0.73 | 0.87 | 1.04 |
Cash ROIC |
(17.84%) | (8.84%) | (7.93%) | (24.51%) | (68.36%) | (40.50%) | 1.97% | (50.79%) | (16.24%) |
Accounts Receivable Turnover |
7.63 | 7.69 | 9.16 | 8.29 | 4.22 | 3.94 | 4.64 | 5.68 | 6.32 |
Accounts Payable Turnover |
16.62 | 22.58 | 40.84 | 32.69 | 27.59 | 18.64 | 22.12 | 22.81 | 20.73 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
28.38 | 7.31 | 11.29 | 10.61 | 12.78 | 24.77 | 10.25 | 20.06 | 13.40 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
5.11 | 5.16 | 4.66 | 4.55 | 5.06 | 6.32 | 5.44 | 3.89 | 3.11 |
Average Payables |
1.06 | 0.88 | 0.54 | 0.65 | 0.60 | 0.79 | 0.72 | 0.60 | 0.61 |
Average Assets |
23.53 | 25.77 | 25.74 | 26.25 | 25.77 | 22.78 | 20.14 | 15.53 | 10.32 |
Average Common Equity |
13.64 | 17.11 | 18.68 | 17.78 | 14.67 | 12.38 | 11.51 | 8.72 | 5.90 |
Columns are period end dates